Skip to main content
Clinical Trials/NCT07088900
NCT07088900RecruitingNot Applicable

The Effectiveness of Dexmedetomidine as an Adjuvant for Bupivacaine Caudal Block in Pediatric Open Appendectomy Under General Anesthesia

Ain Shams University1 site in 1 country60 target enrollmentStarted: August 1, 2025Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
60
Locations
1
Primary Endpoint
Time to First Rescue Analgesia:

Study Overview

Brief Summary

This study aims to evaluate if adding dexmedetomidine to bupivacaine in a caudal block can provide longer and better quality pain relief for children after open appendectomy surgery. The study will also assess the effect of this combination on the quality of recovery, including the incidence of emergence delirium, and its overall safety profile.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
2 Years to 7 Years (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •ASA (American Society of Anesthesiologists) physical status I or II.
  • •Legal guardian provides written informed consent.

Exclusion Criteria

  • •Refusal of participation by the legal guardian.
  • •Known allergy or hypersensitivity to local anesthetics or dexmedetomidine.
  • •Coagulation disorder or receiving anticoagulant therapy.
  • •Active infection at or near the injection site.
  • •Significant anatomical abnormalities of the lumbosacral spine.
  • •Pre-existing neurological disorders, psychiatric disorders, or a history of convulsions.
  • •Anticipated surgery time of more than 2.5 hours.
  • •Patients with severe asthma or active wheezing.

Arms & Interventions

Control Group

Active Comparator

Patients will receive a single-shot caudal block with 1 mL/kg of 0.25% bupivacaine mixed with 1 mL of normal saline.

Intervention: caudal block with bupivacaine (Procedure)

Experimental Group

Experimental

Patients will receive a single-shot caudal block with 1 mL/kg of 0.25% bupivacaine mixed with 1 µg/kg of dexmedetomidine (diluted in 1 mL of normal saline).

Intervention: caudal block using dexmedetomidine with bupivacaine (Procedure)

Outcomes

Primary Outcomes

Time to First Rescue Analgesia:

Time Frame: Up to 24 hours post-caudal block

Defined as the time interval in minutes from the performance of the caudal block until the first administration of rescue analgesia (ibuprofen), which is prompted by a FLACC pain score of ≥ 4.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Mohamed Tarek Hussein

doctor

Ain Shams University

Study Sites (1)

Loading locations...

Similar Trials

The Effectiveness of Dexmedetomidine as an... | Clinical Trial